Grant: Strategic Projects - Group
University of Toronto
$145,500.00
Miniaturized microelectronic devices for cost-effective point-of-care diagnostics
FY 2011-12
Summary
The fields of genomics and proteomics have led to the discovery of molecular fingerprints of diseases. These breakthroughs offer the potential to detect and treat these diseases early, improving the quality of healthcare in Canada and around the world. There is one key missing piece: the technologies to take each patient's molecular fingerprint. Today, these technologies - known as molecular diagnostics - are costly, and can only be run in a centralized clinical lab. They are also prone to false positives. In this proposal, we will advance an innovative technology - one based on miniaturized, low-cost microchips - that will allow us to detect ovarian cancer earlier, more cheaply, and more rapidly. We will partner closely with Kalgene Pharmaceuticals. Kalgene is commercializing a test for ovarian cancer that will be performed in doctors' offices on all post-menopausal women. They urgently require a suitable device for both protein and nucleic acids analysis in unprocessed samples. As a result of this strategic project grant collaboration between researchers at UofT and scientists at Kalgene,
we will deliver a compelling prototype technology that - automatically, in only a single step - gives an answer that can in future aid clinicians in improving patient outcomes. The outcome of the project will be a technology prototype and proof-of-principle
study that paves the way to commercialization of our instrument. The research will be carried out by a highly multidisciplinary team of graduate trainees focused around an applied challenge of obvious societal importance.
Program
Strategic Projects - Group
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
396397-2010
Name nom
Kelley, Shana
Department département
Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
145500
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
2
Nb partie
3
Application title
Miniaturized microelectronic devices for cost-effective point-of-care diagnostics
Keyword
NSERC
Application summary
The fields of genomics and proteomics have led to the discovery of molecular fingerprints of diseases. These breakthroughs offer the potential to detect and treat these diseases early, improving the quality of healthcare in Canada and around the world. There is one key missing piece: the technologies to take each patient's molecular fingerprint. Today, these technologies - known as molecular diagnostics - are costly, and can only be run in a centralized clinical lab. They are also prone to false positives. In this proposal, we will advance an innovative technology - one based on miniaturized, low-cost microchips - that will allow us to detect ovarian cancer earlier, more cheaply, and more rapidly. We will partner closely with Kalgene Pharmaceuticals. Kalgene is commercializing a test for ovarian cancer that will be performed in doctors' offices on all post-menopausal women. They urgently require a suitable device for both protein and nucleic acids analysis in unprocessed samples. As a result of this strategic project grant collaboration between researchers at UofT and scientists at Kalgene,
we will deliver a compelling prototype technology that - automatically, in only a single step - gives an answer that can in future aid clinicians in improving patient outcomes. The outcome of the project will be a technology prototype and proof-of-principle
study that paves the way to commercialization of our instrument. The research will be carried out by a highly multidisciplinary team of graduate trainees focused around an applied challenge of obvious societal importance.